A Umbrella Study in R/R PTCL Guided by Molecular Subtypes

Clinical trial NCT05559008 · UNKNOWN

Trial details

NCT number: NCT05559008
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral T Cell Lymphoma

Start date: 2022-09-30
Primary completion: 2024-03-26
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.